2019 AMERICAN SOCIETY FOR NEURAL THERAPY AND REPAIR

2019 年美国神经治疗与修复学会

• 批准号: 9762479
• 负责人: Kyle Fink
• 金额: $ 2.5万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-01 至 2020-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9762479
• 关键词: Acute Brain Injuries; Acute Disease; Address; Adult; Affect; Age; Alzheimer' s Disease; American; Angelman Syndrome; Area; Award; Basic Science; Biotechnology; Brain; Brain Diseases; Career Choice; Cell Transplantation; Cell Transplants; Clinical; Clinical Trials; Collaborations; Creativeness; Dancing; Data; Development; Diagnosis; Disease; Educational workshop; Emotional; Ensure; Event; Exposure to; Faculty; Family; Fostering; Foundations; Funding; Genetic; Goals; Huntington Disease; Incidence; Industry; Investigation; Lead; Locales; Medical; Medical Students; Methods; Mission; Nervous System Physiology; Neuraxis; Neurodegenerative Disorders; Neurodevelopmental Disorder; Neurologic; Neurologic Dysfunctions; Neurons; Neuropharmacology; Outcome Measure; Parkinson Disease; Patients; Play; Population; Postdoctoral Fellow; Privatization; Procedures; Public Health; Public Health Applications Research; Recovery of Function; Refractory; Research; Research Personnel; Rett Syndrome; Role; Running; Science; Scientist; Senior Scientist; Silicon Dioxide; Social Planning; Societies; Spinal Muscular Atrophy; Spinal cord injury; Stem cells; Stroke; Students; Technology; Therapeutic; Therapeutic exercise; Tissue Engineering; Training; Training and Education; Translating; Translational Research; Transplantation; Traumatic Brain Injury; Travel; United States; United States National Institutes of Health; Wages; Writing; age related neurodegeneration; base; care costs; cohort; cost; disability; gene therapy; graduate student; improved; industry partner; insight; meetings; nervous system disorder; neurogenesis; neurotechnology; novel; novel therapeutics; nutrition; precision medicine; programs; relating to nervous system; repaired; response; socioeconomics; stem cell therapy; therapeutic development; tool; translational approach; undergraduate student

Neurodegenerative disorders such as Alzheimer's disease (AD), Huntington's disease and Parkinson's disease (PD), acute disorders such as traumatic brain injury, spinal cord injury, and stroke, and neurodevelopmental disorders such as Angelman's Syndrome, Rett Syndrome, and Spinal Muscular Atrophy are amongst a plethora of devastating neurological conditions for which there are little to no treatments. As the incidence of many of these disorders increase with age, the number of patients with these disorders is expected to dramatically increase as the US population continues to age. The financial and emotional burden to patients and their families is indescribable; in addition, the cost of care and lost wages is an enormous financial liability for the US economy. The American Society for Neural Therapy and Repair (ASNTR) is a society focused on basic, translational, and clinical aspects of neurological disorders. The ASNTR membership uses cell transplantation, gene therapy, tissue engineering, neuropharmacology, and other cutting-edge technologies to study, and treat, such disorders. The 2019 annual meeting of ASNTR will be held at Sheraton Sand Key, Clearwater Beach, FL. This locale provides for a very unique and intimate setting which promotes interactions between junior trainees and accomplished investigators, as well as fostering unique collaborations. The 2019 meeting will be focused on new directions in neural repair and therapy in the coming decade, and the challenges of translating new therapies. As such, planned sessions will cover the “Precision Medicine in Neurodegenerative disease”, “When to intervene in Neurodegenerative disorders”, and “Emerging Neurotechnologies”. A special session (open to patients) will focus on the current directions and challenges in Parkinson's disease therapeutics. This session will also include a Dancing with PD session, which has become a popular session in past ASNTR meetings. Moreover, ASNTR is tremendously committed to trainees. The society encourages trainee participation in the governance of ASNTR and focuses on the development of trainees. The purpose of this R13 is to garner travel support for top trainees (selected from submitted abstracts) to offset their costs to attend the 2019 meeting. Moreover, in 2019 we have several trainee-activities planned. This includes a workshop “Navigating the Role of Industry Partnerships in Academic Research” with confirmed speakers with expertise in therapeutic development for stem cell and gene therapy from both Biotechnology Companies running clinical trials as well as Senior PIs from academic labs focuses on IND-enabling studies. We will also hold a data blitz for trainees as well as meet-the-editor luncheons. Moreover, we have planned social events, aimed at furthering the interaction between faculty and trainees. ASNTR has a strong track record of fostering young investigators, and we aim to continue in this trajectory. Although we always pursue all methods available (i.e. approach the biotech industry and private foundations) in order to provide travel support for trainees, support from the NIH is crucial in order for us to continue on our strong training mission.

神经退行性疾病，例如阿尔茨海默氏病（AD），亨廷顿氏病和帕金森氏病 （PD），急性疾病，例如脑损伤，脊髓损伤和中风和神经发育 Angelman综合征，RETT综合征和脊柱肌肉萎缩等疾病是 毁灭性神经疾病的毁灭性疾病几乎没有治疗。 许多疾病随着年龄的增长而增加，这些疾病的患者数量被暴露为 随着美国人口的持续增长，财务和情感负担急剧增加。 他们的家人是不明智的； 美国经济。 神经系统疾病的基本，翻译和临床方面。 移植，基因治疗，组织工程，神经药理和其他尖端技术 研究和信任，这种疾病。 2019年ASNTR年度会议将在佛罗里达州Clearwater Beach的Sheraton Sand Key举行 提供了一个非常独特和私密的环境，可促进初级培训和 有成就的调查人员以及培养独特的合作。 未来十年的神经修复和治疗方向的新方向，以及翻译新的挑战 疗法。 干预神经退行性疾病”和“新兴神经技术”。特别会议（开放 患者将重点关注帕金森氏病治疗的挑战和挑战 还将包括与PD会议一起跳舞，该会议已成为过去ASNTR会议中的流行会议。 此外，ASNTR致力于学员。 ASNTR的治理和重点是学员的发展。 对顶级学员（从提交摘要中选择）的支持抵消了参加2019年会议的费用。 此外，在2019年，我们计划了一项“驾驶Rolee”的工作室。 学术研究中的行业合作伙伴关系”，具有治疗方面专业知识的确认发言人 生物技术公司的干细胞和基因治疗疗法的开发也是运行Clinniningls Tet的开发 由于学术实验室的高级PI着重于辅助研究。 除了午餐会，我们还计划了社交活动 教师和学员之间的互动。 我们的目标是继续这一轨迹。 生物技术行业和私人基金会）为了向受训者旅行，NIH的支持是 为了使我们继续执行强大的训练任务，至关重要。